发明名称 NEW TISSUE FACTOR ANTIBODIES AS ANTICOAGULANTS
摘要 FIELD: medicine; biotechnologies. ^ SUBSTANCE: anticoagulative antibody is more affinity fixed to FVIIa/TF complex, than to free TF. Discovered is pharmaceutical composition for thrombosis prevention and treatment, containing the described antibody. Offered is method of thrombosis prevention, consisting in introduction of therapeutically effective amount of the described antibody. Furthermore, offered is method of decrease and treatment of deep venous thrombosis (DVT), disseminated intravascular clotting (DIC), acute coronary artery thrombosis or cancer with coagulopathy signs in the patient, consisting that therapeutically effective amount of the described antibody is introduced to the patient. Discovered is method of inflammatory response regulation in the patient, consisting that therapeutically effective amount of the described antibody is introduced to the patient. Polynucleotide sequence encoding the described antibody is presented. ^ EFFECT: higher efficiency. ^ 24 cl, 10 dwg, 9 ex
申请公布号 RU2345789(C2) 申请公布日期 2009.02.10
申请号 RU20040135306 申请日期 2003.04.30
申请人 SHERING AKTSIENGEZEL'SHAFT 发明人 LAJT DEJVID;MAKLIN KERK
分类号 A61K39/395;C12N15/09;A61K38/00;A61K38/19;A61K48/00;A61L33/00;A61P7/02;A61P9/10;A61P29/00;A61P31/04;A61P35/00;A61P37/06;A61P43/00;C07K14/47;C07K14/485;C07K14/745;C07K16/18;C07K16/28;C07K16/36;C07K16/40;C07K19/00;C12N15/13;C12P21/08;C12Q1/68 主分类号 A61K39/395
代理机构 代理人
主权项
地址
您可能感兴趣的专利